Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events weighing patient doctor benefit risk preferences psoriasis treatments
… to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro …
… Nuria Saigi-Morgui Pharmacoepidemiology and Risk Management Barcelona, Spain PhD, Pharmacogenetics … side effects and pharmacogenetics of psychotropic treatments through an observational clinical study that involved coordination of a multidisciplinary team, patient recruitment, and data collection. She also acquired …
… designs for studies and the resulting data on competitive treatments (pipeline and supportive care). created the …
… will be presented at the 21st BTOG Annual Conference. Patient characteristics and treatment patterns in resectable …
Hem/Onc Pharmacists Assoc (HOPA) Annual Conference Share on: Wednesday, March 30 - Saturday, April 2, 2022 Conference Website Research coauthored by Shardul Odak of RTI Health Solutions will be presented at the Hem/Onc Pharmacists Assoc (HOPA) Annual …
2022 International Thoracic Surgical Oncology Summit Share on: Friday, September 30 - Saturday, October 1, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the 2022 International Thoracic Surgical …
… the 2022 American Society of Clinical Psychopharmacology. Risk of mortality associated with Pimavanserin compared with …
… of life and tolerability of loncastuximab tesirine in high-risk patients with relapsed/refractory diffuse large B-cell …
Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022) Share on: Wednesday, September 28 - Saturday, October 1, 2022 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at the Tenth Annual Meeting …
… help answer. Key Factors Key Questions About Your Product Patient Perspective Can I afford it? Is it easy for me to … How have payers handled reimbursement of alternative treatments? HEOR Strategy What additional studies will be …